With Measles Roaring Back, the Search for a Drug is On - The New York Times
• Declining vaccination rates have led to a resurgence of measles, prompting biotech companies and researchers to seek pharmaceutical treatments for the disease. • Dr. Plemper of Georgia State University is working on a drug that could potentially be used off-label to treat measles patients if approved. • Experts, including Dr. Mina, emphasize that while new treatments are necessary to prevent deaths, widespread vaccination remains the only effective way to stop the outbreaks.
nytimes.com






